ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Berlin, BE

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near Berlin, BE, DEU:

Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer (PATINA)

to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...

Active, not recruiting
Estrogen Receptor Positive Breast Cancer
HER-2 Positive Breast Cancer
Drug: palbociclib
Drug: trastuzumab

Phase 3

Alliance Foundation Trials

Berlin, Germany and 117 other locations

This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...

Active, not recruiting
Breast Cancer
Drug: Trastuzumab
Drug: Trastuzumab deruxtecan

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Berlin, Germany and 226 other locations

look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast...

Active, not recruiting
HER2-positive Early Breast Cancer
Breast Cancer
Drug: Pertuzumab
Drug: Paclitaxel

Phase 3

AstraZeneca
AstraZeneca

Berlin, Germany and 147 other locations

This is a single-arm, open-label phase IV study of patients with advanced HR+/HER2- breast cancer who are treated first line with r...

Enrolling
Breast Cancer
Breast Cancer Female
Drug: Ribociclib

Phase 4

Institute for Women's Health (IFG)

Berlin, Germany and 51 other locations

Locations recently updated

A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....

Enrolling
Advanced Breast Cancer
Drug: ARV-471
Drug: Fulvestrant

Phase 3

Pfizer
Pfizer

Berlin, Germany and 446 other locations

(BMs), with previously-treated advanced/metastatic HER2-positive breast cancer whose disease has progressed on prior anti-HER2-base...

Active, not recruiting
Breast Cancer
Drug: Trastuzumab Deruxtecan

Phase 3

AstraZeneca
AstraZeneca

Berlin, Germany and 80 other locations

PREcoopERA is a randomized (2:2:1), multicenter, open-label, three-arm (A, B, C), Window-of-Opportunity (WOO) trial to evaluate the activity and safe...

Enrolling
Breast Cancer
Drug: Triptorelin
Drug: Anastrozole

Phase 2

ETOP IBCSG Partners Foundation

Berlin, Germany and 43 other locations

The treatment of patients with HER2 positive early breast cancer has continuously improved over the last decades. Up to now both, t ...

Enrolling
Breast Cancer
Breast Cancer Female
Drug: Chemotherapy
Drug: Pertuzumab

Phase 4

Institute for Women's Health (IFG)

Berlin, Germany and 10 other locations

Phase III, prospective, multi-center, randomized, open label, parallel group, study in patients with HER2-negative breast cancer wi...

Active, not recruiting
Triple Negative Breast Cancer
HER2-negative Breast Cancer
Drug: Sacituzumab govitecan
Drug: Cisplatin

Phase 3

German Breast Group (GBG) Research

Berlin, Germany and 162 other locations

with hormone receptor-positive (HR-positive), HER2-negative advanced breast cancer (aBC) who have not received prior therapy for ad...

Active, not recruiting
Breast Cancer
Drug: Letrozole
Drug: Anastrozole

Phase 2

Novartis
Novartis

Berlin, Germany and 89 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems